Shanghai Shyndec Pharmaceutical Co.,Ltd.’s Net Profit Rose 55.9% in First Half of 2023

Shanghai Shyndec Pharmaceutical Co.,Ltd. (上海现代制药股份有限公司) (600420.SH) reported a net profit of 514.5 million yuan in the first half of 2023, up 55.9% year-on-year.

Meanwhile, the company posted 6.4 billion yuan in revenue, up 0.9% year-on-year.

At the end of the reporting period, it had 19 billion yuan in total assets and 5 billion yuan in total liabilities, with a liability-to-asset ratio of 26.3%.